India's Shilpa Medicare jumps on government nod for oral spray

Shilpa Medicare

12/10/2023 07:17

** Shares of Shilpa Medicare  SHME.NS  rise as much as
6.15%, biggest intraday pct gain in more than a month, to 358.20
rupees
    ** Pharma company receives approval from Ministry of Ayush
for the sale of oral spray to treat mucositis
    ** The oral spray to be made available for the first time in
India under the brand name ORAAL
    ** Stock most active since Aug. 31 with trading volume at
862,813 as of 11:29 a.m. IST, more than thrice the 30-day avg -
LSEG data
    ** Including today's gains, SHME up 25% in 2023 so far vs
20.5% rise in Nifty Pharma index  .NIPHARM 

 (Reporting by Bharath Rajeswaran in Bengaluru)
 ((bharath.rajeswaran@thomsonreuters.com; +91 9769003463))